These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 207172)

  • 21. [Pharmacology of prostacyclin].
    Imai S
    Kokyu To Junkan; 1985 Jul; 33(7):845-9. PubMed ID: 2997894
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of adenosine 3':5'-monophosphate and platelet aggregation on thromboxane biosynthesis in human platelets.
    Lindgren JA; Claesson HE; Kindahl H; Hammarström S
    FEBS Lett; 1979 Feb; 98(2):247-50. PubMed ID: 217731
    [No Abstract]   [Full Text] [Related]  

  • 23. Reciprocal regulation of human platelet cAMP levels by thromboxane A2 and prostacyclin.
    Gorman RR; Fitzpatrick FA; Miller OV
    Adv Cyclic Nucleotide Res; 1978; 9():597-609. PubMed ID: 208399
    [No Abstract]   [Full Text] [Related]  

  • 24. Blood platelet function, medicinal agents, and other chemical entities.
    Lasslo A
    Fed Proc; 1984 Apr; 43(5):1382-9. PubMed ID: 6323230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of prostaglandins, thromboxanes and prostacyclin in regulating the thrombocyte aggregation process and liberation reaction normally and in pathology].
    Baluda VP; Sushkevich GN; Lukoianova TI
    Patol Fiziol Eksp Ter; 1980; (4):80-5. PubMed ID: 6251418
    [No Abstract]   [Full Text] [Related]  

  • 27. Functional pool of cyclic adenosine 3',5'-monophosphate in rabbit platelets.
    Hashimoto S
    Thromb Haemost; 1983 Feb; 49(1):8-12. PubMed ID: 6302940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased platelet adenylate cyclase activity ion diabetic patients with microangiography.
    Janka HU; Standl E; Mehnert H
    Horm Metab Res Suppl; 1981; 11():26-9. PubMed ID: 6172351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Model of prostaglandin-regulated cyclic AMP metabolism in intact platelets: examination of time-dependent effects on adenylate cyclase and phosphodiesterase activities.
    Ashby B
    Mol Pharmacol; 1989 Dec; 36(6):866-73. PubMed ID: 2481225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of CI-930, a novel phosphodiesterase III inhibitor, on platelet aggregation and arachidonic acid metabolism.
    Chen XS; Zeng HW; Jiang YY; Wan WQ; Long K
    Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):338-43. PubMed ID: 1966575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties.
    Needleman P; Raz A; Minkes MS; Ferrendelli JA; Sprecher H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):944-8. PubMed ID: 218223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The distribution and metabolism of arachidonic acid in rabbit platelets during aggregation and its modification by drugs.
    Blackwell GJ; Duncombe WG; Flower RJ; Parsons MF; Vane JR
    Br J Pharmacol; 1977 Feb; 59(2):353-66. PubMed ID: 837023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phospholipid metabolism in stimulated human platelets. Changes in phosphatidylinositol, phosphatidic acid, and lysophospholipids.
    Broekman MJ; Ward JW; Marcus AJ
    J Clin Invest; 1980 Aug; 66(2):275-83. PubMed ID: 7400315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Enhancement of platelet function in cholesterol-fed guinea-pigs].
    Maeda J; Tsuboi T; Fujitani B; Kadokawa T; Shimizu M
    Nihon Yakurigaku Zasshi; 1982 Aug; 80(2):105-11. PubMed ID: 6293944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders.
    Gresele P; Blockmans D; Deckmyn H; Vermylen J
    J Pharmacol Exp Ther; 1988 Jul; 246(1):301-7. PubMed ID: 3134542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cyclic nucleotides and blood platelet functions].
    Kuramoto A
    Nihon Rinsho; 1978 Dec; 36(12):3813-8. PubMed ID: 34743
    [No Abstract]   [Full Text] [Related]  

  • 38. Mobilization of arachidonic acid in human platelets. Kinetics and Ca2+ dependency.
    Rittenhouse-Simmons S; Russell FA; Deykin D
    Biochim Biophys Acta; 1977 Sep; 488(3):370-80. PubMed ID: 901795
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of lipids in platelet function: with particular reference to the arachidonic acid pathway.
    Marcus AJ
    J Lipid Res; 1978 Sep; 19(7):793-826. PubMed ID: 101634
    [No Abstract]   [Full Text] [Related]  

  • 40. Rapid inactivation of cyclooxygenase activity after stimulation of intact platelets.
    Lapetina EG; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1979 Jan; 76(1):121-5. PubMed ID: 218191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.